Wegovy News
Latest articles and news about Wegovy on AXL Media.
Latest Articles
- Why GLP-1 Medications Fail for 20% of Users: Research Suggests Combination Therapy as a Potential Solution
Published: May 1, 2026
Section: Fitness & Exercise
While GLP-1 receptor agonists like Wegovy and Zepbound have revolutionized weight management, a significant subset of users—as many as one in five—experience suboptimal results. Ne...
- Endoscopic "gut reset" procedure prevents weight rebound after stopping Ozempic and Wegovy
Published: Apr 23, 2026
Section: Research
A new minimally invasive technique called duodenal mucosal resurfacing (DMR) could solve the "weight regain" paradox for patients discontinuing GLP-1 medications. Clinical trial re...
- GLP-1 Weight Loss Study Reveals Higher Social Stigma and "Shortcut" Biases Against White Women
Published: Apr 18, 2026
Section: Mental Health
A new study from Georgetown University finds that women using GLP-1 medications for weight loss face significantly harsher social judgment than those using traditional diet and exe...
- FDA Grants Approval for High-Dose Wegovy as Novo Nordisk Battles Eli Lilly for Weight-Loss Dominance
Published: Apr 2, 2026
Section: Science & Tech
The Food and Drug Administration has approved a 7.2-milligram dose of Novo Nordisk’s weight-loss injection, Wegovy, aimed at closing the efficacy gap with rival medications. Clinic...
- UK Drug Watchdog Backs Novo Nordisk's Wegovy for Heart Disease Prevention via NHS
Published: Apr 1, 2026
Section: Companies & Industry
The National Institute for Health and Care Excellence (NICE) has recommended Wegovy for reducing the risk of heart attacks and strokes in obese adults. This landmark decision allow...
- Stanford Study Identifies Python Blood Metabolite That Mimics Modern Weight Loss Drugs
Published: Mar 19, 2026
Section: Science & Tech
Researchers at Stanford Medicine and the University of Colorado Boulder have discovered that a metabolite called pTOS, which spikes a thousandfold in pythons after feeding, induces...
- Study Finds Preterm Birth Risk Linked to Underlying Diabetes Rather Than Inadvertent GLP-1 Weight Loss Drug Exposure
Published: Mar 18, 2026
Section: Health
A massive Danish study of over 750,000 pregnancies has determined that while weight-loss drugs like Ozempic are associated with a higher risk of premature birth, the danger appears...
- High-Dose Wegovy Linked to Significantly Higher Risk of Sudden Sight Loss and "Eye Stroke" Compared to Other Semaglutide Medications
Published: Mar 12, 2026
Section: Research
A new analysis of FDA adverse event reports published in the British Journal of Ophthalmology reveals that the weight-loss drug Wegovy is associated with a five-fold higher risk of...
- Wegovy Linked To Higher Risks Of Ischaemic Optic Neuropathy And Sudden Vision Loss Than Other Semaglutide Medications
Published: Mar 11, 2026
Section: Health
A comprehensive analysis published in the British Journal of Ophthalmology suggests that Wegovy, a high-dose semaglutide used for weight loss, carries a significantly higher risk o...
- Global Health Breakthrough: Semaglutide Production Costs Could Plunge to US$3 Monthly as Patents Expire
Published: Mar 6, 2026
Section: Medical News
A new study by researchers from Britain, South Africa, and New Zealand suggests that the manufacturing cost of semaglutide—the active ingredient in Ozempic and Wegovy—could drop to...
- New research suggests glp 1 weight loss drugs may assist heart recovery by restoring microvascular blood flow
Published: Mar 5, 2026
Section: Medical News
A study from the University of Bristol and University College London indicates that medications like Ozempic and Mounjaro could prevent secondary heart damage after a heart attack....
- New Survey Reveals 1 in 8 U.S. Adults Have Used Ozempic or Similar GLP-1 Medications
Published: Mar 3, 2026
Section: Healthy Lifestyle
A landmark survey released by KFF (Kaiser Family Foundation) has revealed the staggering reach of GLP-1 receptor agonists in the United States. According to the data, approximately...